Carrier System

BioEqual has developed a ground-breaking topical treatment against fungal nail infections (onychomycosis). Boasting a unique carrier-system, this allows the soluble (pharmacologically) active antifungal agents to effectively penetrate the infected nail unchanged through the nail to the actual site of the infection, the nail-bed.

 

 

 

Growth Factor Complex (GFC)

BioEqual has developed a patented method to isolate and activate a growth factors complex (GFC) from natural sources. In preclinical assay tests in cell cultures, it has shown that GFC has a very positive effect on cell proliferation, differentiation and migration, offering the advantage to influence juvenile fibroblasts in contrast to keratinocytes dominating in aged skin. This activity is in first line to ascribe the presence of TGF-β (Transforming Growth Factor-Beta) as well as the growth factors and proteins with growth-factor-like activity, contained in the mother milk of mammals. Furthermore, it has been clearly demonstrated that GFC is able to stimulate the growth factor receptor cascades.

These promising results have allowed us to develop a line of galenical formulations for different skin applications. Positive results have been reported in the treatment of a variety of dermatological disorders including skin irritations, ulcera, wound-healing and burns, amongst others.

Our products which embrace these technologies and patents are categorized into 2 market segments: dermatological products and orthopaedic products.